Hipercinesia en la niñez; ADHD; ADD
Aunque no existe una forma comprobada de prevenir el trastorno de hiperactividad y déficit de atención en sí, su identificación y tratamiento oportunos pueden prevenir muchos de los problemas asociados con dicho trastorno.
American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000; 105(5). 1158-1170.
US Food and Drug Administration. FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Events. Rockville, MD: National Press Office; February 21, 2007. Report P07-26.
This article uses information by permission from Alan Greene, M.D., © Greene Ink, Inc.
![]() | A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |